Your browser doesn't support javascript.
loading
Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis.
Ishii, Tsuyoshi; Matsue, Yuya; Matsunaga, Yuki; Iekushi, Kazuma; Homma, Yuji; Morita, Yohei.
Affiliation
  • Ishii T; Novartis Pharma K.K., Tokyo, Japan.
  • Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. yuya8950@gmail.com.
  • Matsunaga Y; Novartis Pharma K.K., Tokyo, Japan.
  • Iekushi K; Novartis Pharma K.K., Tokyo, Japan.
  • Homma Y; JMDC Inc., Tokyo, Japan.
  • Morita Y; Novartis Pharma K.K., Tokyo, Japan.
Heart Vessels ; 39(1): 25-34, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37695543

Full text: 1 Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Heart Failure Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Heart Vessels Journal subject: CARDIOLOGIA Year: 2024 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Heart Failure Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Heart Vessels Journal subject: CARDIOLOGIA Year: 2024 Type: Article Affiliation country: Japan